These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1380407)

  • 1. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
    Chen TL; Erlichman C
    Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.
    Erlichman C; Mitrovski B
    Cancer Chemother Pharmacol; 1994; 34(1):51-6. PubMed ID: 8174202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.
    Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
    Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH
    Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
    van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
    Berger SH; Hakala MT
    Mol Pharmacol; 1984 Mar; 25(2):303-9. PubMed ID: 6608049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.
    Berne MH; Gustavsson BG; Almersjö O; Spears PC; Frösing R
    Cancer Chemother Pharmacol; 1986; 16(3):237-42. PubMed ID: 3698165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical modulation of 5-fluorouracil with brequinar: results of a phase I study.
    Buzaid AC; Pizzorno G; Marsh JC; Ravikumar TS; Murren JR; Todd M; Strair RK; Poo WJ; Hait WN
    Cancer Chemother Pharmacol; 1995; 36(5):373-8. PubMed ID: 7634378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools.
    Pizzorno G; Wiegand RA; Lentz SK; Handschumacher RE
    Cancer Res; 1992 Apr; 52(7):1660-5. PubMed ID: 1551097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
    Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation.
    Spears CP; Hayes AA; Shahinian AH; Danenberg PV; Frösing R; Gustavsson BG
    Biochem Pharmacol; 1989 Sep; 38(18):2985-93. PubMed ID: 2783153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy.
    Bertino JR; Mini E; Fernandes DJ
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells.
    Romanini A; Li WW; Colofiore JR; Bertino JR
    J Natl Cancer Inst; 1992 Jul; 84(13):1033-8. PubMed ID: 1376779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an LC-MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil.
    Derissen EJ; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH
    J Pharm Biomed Anal; 2015 Jun; 110():58-66. PubMed ID: 25804433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor.
    Sato S; Kohno K; Hidaka K; Hisatsugu T; Kuwano M; Komiyama S
    Anticancer Drug Des; 1993 Aug; 8(4):289-97. PubMed ID: 8240657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dose and interval between 5-fluorouracil and leucovorin on the formation of thymidylate synthase ternary complex in human cancer cells.
    Drake JC; Voeller DM; Allegra CJ; Johnston PG
    Br J Cancer; 1995 Jun; 71(6):1145-50. PubMed ID: 7779703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of acquired resistance to modulation of 5-fluorouracil by leucovorin in HCT-8 human ileocecal carcinoma cells.
    Lu K; McGuire JJ; Slocum HK; Rustum YM
    Biochem Pharmacol; 1997 Mar; 53(5):689-96. PubMed ID: 9113088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil.
    Peters GJ; van der Wilt CL; van Groeningen CJ; Smid K; Meijer S; Pinedo HM
    J Clin Oncol; 1994 Oct; 12(10):2035-42. PubMed ID: 7931471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.